Arcarios Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Arcarios General Information

Description

Provider of drug development services intended for the treatment of bones and joint diseases. The company's drug development services dedicated to the discovery and development of innovative products, enabling users to get durable treatments, validated through controlled clinical trials for damaged and diseased skeletal tissues.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Dr. Molewaterplein 40
  • Rotterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Dr. Molewaterplein 40
  • Rotterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcarios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2016 Completed Out of Business
3. Grant 16-Nov-2011 Completed Generating Revenue
2. Secondary Transaction - Private $5.31M Completed Generating Revenue
1. Seed Round 25-Aug-2010 $5.31M $5.31M Completed Generating Revenue
To view Arcarios’s complete valuation and funding history, request access »

Arcarios Patents

Arcarios Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014187807-A1 Follistatin derivatives Inactive 21-May-2013
EP-2550299-A2 Substituted cyclodextrin derivatives and process for their preparation Inactive 24-Mar-2010
WO-2011117317-A3 Substituted cyclodextrin derivatives and process for their preparation Inactive 24-Mar-2010
CA-2792961-A1 Substituted cyclodextrin derivatives useful as intermediates for producing biologically active materials Inactive 24-Mar-2010
US-20130046087-A1 Substituted cyclodextrin derivatives useful as intermediates for producing biologically active materials Inactive 24-Mar-2010 C08B37/0012
To view Arcarios’s complete patent history, request access »

Arcarios Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcarios Acquisitions (1)

Arcarios’s most recent deal was a Merger of Equals with Therosteon. The deal was made on 25-Aug-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Therosteon 25-Aug-2010 Merger of Equals Biotechnology
To view Arcarios’s complete acquisitions history, request access »

Arcarios FAQs

  • When was Arcarios founded?

    Arcarios was founded in 2010.

  • Where is Arcarios headquartered?

    Arcarios is headquartered in Rotterdam, Netherlands.

  • What is the size of Arcarios?

    Arcarios has 5 total employees.

  • What industry is Arcarios in?

    Arcarios’s primary industry is Drug Discovery.

  • Is Arcarios a private or public company?

    Arcarios is a Private company.

  • What is Arcarios’s current revenue?

    The current revenue for Arcarios is .

  • How much funding has Arcarios raised over time?

    Arcarios has raised $5.31M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process